Literature DB >> 6416918

Budd-Chiari syndrome in a patient with the lupus anticoagulant.

C Pomeroy, R G Knodell, W R Swaim, P Arneson, M L Mahowald.   

Abstract

Lupus anticoagulant is an immunoglobulin that interferes with prothrombin conversion to thrombin and is manifested biochemically by prolongation of the partial thromboplastin time. Paradoxically, bleeding is rare in association with this anticoagulant, and deep leg vein thromboses, pulmonary emboli, and cerebrovascular accidents have been described in patients with this clotting inhibitor. This report describes the first case of Budd-Chiari syndrome associated with the lupus anticoagulant. The patient presented with abdominal pain and massive ascites. The Budd-Chiari syndrome was confirmed by liver biopsy and venography. No medical condition known to predispose to an increased thrombotic tendency could be identified, and the presence of the lupus anticoagulant in the patient's plasma may provide an explanation for his hypercoagulability and development of the Budd-Chiari syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6416918

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant.

Authors:  M Averbuch; Y Levo
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

3.  Massive hepatic infarction in systemic lupus erythematosus.

Authors:  G Khoury; M Tobi; M Oren; Y M Traub
Journal:  Dig Dis Sci       Date:  1990-12       Impact factor: 3.199

4.  Liver transplantation in a patient with primary antiphospholipid syndrome and Budd-Chiari syndrome.

Authors:  Tatiana M Reshetnyak; Natalia V Seredavkina; Maria A Satybaldyeva; Evgeniy L Nasonov; Vasiliy I Reshetnyak
Journal:  World J Hepatol       Date:  2015-09-08

5.  [Inflammatory diseases with liver and joint involvement. A differential diagnostic challenge].

Authors:  M Sebode; C Schramm; A W Lohse
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743

Review 6.  Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies.

Authors:  M S Cappell; N Mikhail; N Gujral
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

7.  Suprahepatic Budd-Chiari syndrome treated with thrombectomy and cavoplasty.

Authors:  John Rhee; Anthony J Demetris; Kareem Abu Elmagd; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

8.  Anti-cardiolipin antibodies in ischaemic heart disease.

Authors:  P Klemp; R C Cooper; F J Strauss; E R Jordaan; J Z Przybojewski; N Nel
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

9.  Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment.

Authors:  R J Ouwendijk; J C Koster; J H Wilson; J Stibbe; J S Lameris; W Visser; J P Benhamou
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

Review 10.  Systemic thrombolysis for acute, severe Budd-Chiari syndrome.

Authors:  Paul J Clark; Richard E Slaughter; Dorothy J Radford
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.